News Iconovo AB

Equities

ICO

SE0010868943

Market Closed - Nasdaq Stockholm Other stock markets 10:05:22 2024-05-02 am EDT			5-day change	1st Jan Change
8.04 ^SEK	-0.74%		+2.03%	-30.39%

Apr. 25	Iconovo AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 11	Iconovo AB and Affilogic to Present Positive Data from a Feasibility Study on Nanofitins in ICOone	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Iconovo Q1 - Solid quarter with a near-term catalyst on the horizon	Apr. 26	AQ
Iconovo AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Iconovo to present positive data from a feasibility study on Nanofitins® in ICOone®	Mar. 11	AQ
Iconovo AB and Affilogic to Present Positive Data from a Feasibility Study on Nanofitins in ICOone	Mar. 11	CI
Iconovo receives grant of SEK 680,000 from Innowwide for market efforts in South Korea	Mar. 05	AQ
Iconovo Q4 - Aligned with our expectations and a directed issue announcement	Feb. 19	AQ
Iconovo AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Iconovo AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Iconovo carries out a directed share issue of SEK 33.3 million, partly subject to subsequent approval by the Extraordinary General Meeting, and brings forward the publication of the year-end report	Feb. 15	AQ
Iconovo signs additional contract with Kiox Pharma for the development of a new inhalable treatment for interstitial lung disease	Feb. 07	AQ
Iconovo AB Signs Additional Contract with Kiox Pharma for the Development of A New Inhalable Treatment for Interstitial Lung Disease	Feb. 07	CI
Iconovo launches improved versions of nasal ICOone® inhalers	Feb. 06	AQ
Iconovo AB Launches Improved Versions of Nasal ICOone Inhalers	Feb. 06	CI
Iconovo receives order from Top-10 Pharma company for evaluation of multi-dose inhaler	Feb. 01	AQ
Iconovo Receives Order from Top-10 Pharma Company for Evaluation of Multi-Dose Inhaler	Feb. 01	CI
Iconovo recruits Gary Pitcairn (PhD) as Senior Scientific Advisor	Jan. 08	AQ
Redeye Initiates Coverage of Iconovo	Dec. 06	AQ
Iconovo AB changes liquidity provider and Certified Adviser to Carnegie Investment Bank AB (publ)	Nov. 30	AQ
Nomination Committee appointed at Iconovo AB	Nov. 29	AQ
BioStock: Busy days for Iconovo at BIO-Europe	Nov. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Iconovo AB

Equities

ICO

SE0010868943

Summary

Filters